Panel approves third shot for children and AstraZeneca COVID-19 treatment


A health ministry panel of experts approved on Monday a third dose of the Pfizer coronavirus vaccine for children between the ages of 5 and 11.

The move is hoped to help prevent children in that age group from getting infected with COVID-19 and developing severe symptoms, as the nation continues to see high levels of coronavirus infections driven by the highly infectious BA.5 omicron subvariant.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)



Source link